Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Filed Mar 1, 2022 · 10-K · 60 days after period end · 0001410578-22-000244
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $503.00K | $897.00K | — |
| Net Income | $133.32M | -$280.50M | $6.67M | -$5.65M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 1, 2022 · 60 d after period end
